Related references
Note: Only part of the references are listed.Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Novel molecules as the emerging trends in cancer treatment: an update
Priyanka Sekar et al.
MEDICAL ONCOLOGY (2022)
A survey of herbal medicines as tumor microenvironment-modulating agents
Chan-Ran Park et al.
PHYTOTHERAPY RESEARCH (2021)
Targeting of cancer cell death mechanisms by resveratrol: a review
Xiao Fu et al.
APOPTOSIS (2021)
Utility of comprehensive genomic profiling in directing treatment and improving patient outcomes in advanced non-small cell lung cancer
Shen Zhao et al.
BMC MEDICINE (2021)
Resveratrol induces PD-L1 expression through snail-driven activation of Wnt pathway in lung cancer cells
Mengmeng Yang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Macrophages and cancer stem cells: a malevolent alliance
Paola Allavena et al.
MOLECULAR MEDICINE (2021)
Hiltonol Cocktail Kills Lung Cancer Cells by Activating Cancer-Suppressors, PKR/OAS, and Restraining the Tumor Microenvironment
Shu-Chun Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Onco-Preventive and Chemo-Protective Effects of Apple Bioactive Compounds
Linda Nezbedova et al.
NUTRIENTS (2021)
Advances in systemic therapy for non-small cell lung cancer
Meagan Miller et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Cell competition in intratumoral and tumor microenvironment interactions
Taylor M. Parker et al.
EMBO JOURNAL (2021)
Mechanism of Drug Tolerant Persister Cancer Cells: The Landscape and Clinical Implication for Therapy
Masashi Mikubo et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities
Li-Feng Hu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
Role of Intra- and Extracellular Lipid Signals in Cancer Stemness and Potential Therapeutic Strategy
Jianming Hu et al.
FRONTIERS IN PHARMACOLOGY (2021)
FRK plays an oncogenic role in non-small cell lung cancer by enhancing the stemness phenotype via induction of metabolic reprogramming
Li Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Effect of SIRT1 activators and inhibitors on CD44+/CD133+-enriched non-small cell lung cancer cells
Zuhal Eroglu et al.
MOLECULAR MEDICINE REPORTS (2020)
NAF-1 Inhibition by Resveratrol Suppresses Cancer Stem Cell-Like Properties and the Invasion of Pancreatic Cancer
Tao Qin et al.
FRONTIERS IN ONCOLOGY (2020)
Resveratrol Suppresses Cross-Talk between Colorectal Cancer Cells and Stromal Cells in Multicellular Tumor Microenvironment: A Bridge between In Vitro and In Vivo Tumor Microenvironment Study
Constanze Buhrmann et al.
MOLECULES (2020)
Resveratrol exerts antitumor effects by downregulating CD8(+)CD122(+) Tregs in murine hepatocellular carcinoma
Qunfang Zhang et al.
ONCOIMMUNOLOGY (2020)
Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting
Win Sen Heng et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes
Deborah B. Doroshow et al.
CLINICAL CANCER RESEARCH (2019)
Tumor-induced peripheral immunosuppression promotes brain metastasis in patients with non-small cell lung cancer
Yuping D. Li et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer
Alejandro Herreros-Pomares et al.
CELL DEATH & DISEASE (2019)
TGIF2 promotes the progression of lung adenocarcinoma by bridging EGFR/RAS/ERK signaling to cancer cell stemness
Renle Du et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
An Autocrine IL-6/IGF-1R Loop Mediates EMT and Promotes Tumor Growth in Non-small Cell Lung Cancer
Xianan Zheng et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
GSK3 suppression upregulates β-catenin and c-Myc to abrogate KRas-dependent tumors
Aslamuzzaman Kazi et al.
NATURE COMMUNICATIONS (2018)
IL-6 mediates platinum -induced enrichment of ovarian cancer stem cells
Yinu Wang et al.
JCI INSIGHT (2018)
miR-19 targeting of GSK3β mediates sulforaphane suppression of lung cancer stem cells
Jianyun Zhu et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2017)
Effects of Resveratrol against Lung Cancer: In Vitro and In Vivo Studies
Michael Yousef et al.
NUTRIENTS (2017)
Interleukin-6 blockade attenuates lung cancer tissue construction integrated by cancer stem cells
Hiroyuki Ogawa et al.
SCIENTIFIC REPORTS (2017)
The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6
Yuan Yin et al.
CLINICAL CANCER RESEARCH (2017)
Molecular Pathways: Revisiting Glycogen Synthase Kinase-3β as a Target for the Treatment of Cancer
Amy Walz et al.
CLINICAL CANCER RESEARCH (2017)
IL-6 promotes growth and epithelial-mesenchymal transition of CD133+cells of non-small cell lung cancer
Soo Ok Lee et al.
ONCOTARGET (2016)
Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement
Rashmi Bharti et al.
CANCER LETTERS (2016)
Lung cancer stem cells: The root of resistance
Lauren MacDonagh et al.
CANCER LETTERS (2016)
Cisplatin treatment increases stemness through upregulation of hypoxia-inducible factors by interleukin-6 in non-small cell lung cancer
Fuquan Zhang et al.
CANCER SCIENCE (2016)
Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells
Kyle McIntosh et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Tumorigenic lung tumorospheres exhibit stem-like features with significantly increased expression of CD133 and ABCG2
Wensi Zhao et al.
MOLECULAR MEDICINE REPORTS (2016)
Interleukin-6 Prevents the Initiation but Enhances the Progression of Lung Cancer
Zhaoxia Qu et al.
CANCER RESEARCH (2015)
Activation of IL6/IGFIR Confers Poor Prognosis of HBV-Related Hepatocellular Carcinoma through Induction of OCT4/NANOG Expression
Te-Sheng Chang et al.
CLINICAL CANCER RESEARCH (2015)
Enrichment and characterization of cancer stem cells from a human non-small cell lung cancer cell line
Changhong Zhao et al.
ONCOLOGY REPORTS (2015)
Aberrantly expressed miR-582-3p maintains lung cancer stem cell-like traits by activating Wnt/β-catenin signalling
Lishan Fang et al.
NATURE COMMUNICATIONS (2015)
Identification of stem-like cells in non-small cell lung cancer cells with specific peptides
Anxin Wang et al.
CANCER LETTERS (2014)
Wnt Signaling Pathway in Non-Small Cell Lung Cancer
David J. Stewart
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Notch Pathway Activity Identifies Cells with Cancer Stem Cell-like Properties and Correlates with Worse Survival in Lung Adenocarcinoma
Khaled A. Hassan et al.
CLINICAL CANCER RESEARCH (2013)
Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy
Chin Hao Chang et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest
L. Lundholm et al.
CELL DEATH & DISEASE (2013)
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
Jeffrey A. Magee et al.
CANCER CELL (2012)
Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis
Yi-Ping Yang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Impairment of tumor-initiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment
Fang-Wei Hu et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2012)
Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium
Eugenia C. Pacheco-Pinedo et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Wnt/β-catenin signaling regulates cancer stem cells in lung cancer A549 cells
Ying Teng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Up-Regulation of Interleukin-17 Expression by Human Papillomavirus Type 16 E6 in Nonsmall Cell Lung Cancer
Yih-Hsin Chang et al.
CANCER (2010)
Epigenetic control of the basal-like gene expression profile via Interleukin-6 in breast cancer cells
Laura D'Anello et al.
MOLECULAR CANCER (2010)
Bcl-2 Family Proteins Contribute to Apoptotic Resistance in Lung Cancer Multicellular Spheroids
Tsung-Ming Yang et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor Growth
Hui Wang et al.
STEM CELLS (2009)
Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling
Ilaria Malanchi et al.
NATURE (2008)
Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas
Sizhi Paul Gao et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis
Brooke Ancrile et al.
GENES & DEVELOPMENT (2007)
Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells
Aruna Kode et al.
RESPIRATORY RESEARCH (2006)
Autocrine interleukin-6/interleukin-6 receptor stimulation in non-small-cell lung cancer
Eric B. Haura et al.
CLINICAL LUNG CANCER (2006)
Share Paper
